- 1. (-)-Phenylisopropylmethylpropynylamine
- [The hydrochloride salt form of selegiline, a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. As a selective monoamine oxidase (MAO) inhibitor, selegiline has the greatest affinity for type B MAO, found mainly in the brain. Selegiline is converted by MAO B to an active moiety, which binds irreversibly at the active site of the enzyme's cofactor FAD (flavin adenine dinucleotide) molecule. This prevents the oxidative deamination of catecholamines and serotonin by MAO B, and leads to an increase in these neurotransmitters' activities resulting in improved motor function. In addition, this agent may inhibit re-uptake of dopamine by the neuron and prolong dopamine activity. ( NCI )] (UMLS (NCI) C0700467) =Organic Chemical; Pharmacologic Substance =l-Deprenyl;
=SELEGILINE HYDROCHLORIDE 5 MG;
| - 51. Pharmacist
- (UMLS (HL7) C1546966) =Idea or Concept =Primary Observer's Qualification;
|
- 2. 1,1',1"-phosphinothioylidynetrisaziridine
- [alkylating agent used as an antineoplastic in the treatment of carcinoma of the breast, ovary, and bladder, malignant infusions and lymphomas. ( CSP )] (UMLS (NCI) C0039871) =Organophosphorus Compound; Pharmacologic Substance; Hazardous or Poisonous Substance =[AN000] ANTINEOPLASTICS;
Organothiophosphorus Compounds;
Triethylenephosphoramide;
Aminoethylene;
Antineoplastic Alkylating Agent;
=THIOTEPA 15 MG | - 52. Pharmacist
- [An individual who is licensed to prepare and sell or dispense drugs and compounds and to make up prescriptions.Source: Dorland's Illustrated Medical Dictionary, 26th Edition, Philadelphia: W.. Saunders Company, 1981. ( HL7V3.0 )] (UMLS (HL7) C1610714) =Intellectual Product =Pharmacy Service Providers;
=Nutrition Support;
Pharmacotherapy;
Psychopharmacy;
General Practice;
Nuclear Pharmacy;
|
- 3. 1,10-(1,2-Phenylene)pyrene
- [A yellowish, aromatic hydrocarbon consisting of six fused rings and produced by the incomplete combustion of organic matter. Indene[1,2,3-cd]pyrene is primarily found in certain foods, gasoline and diesel exhaust, cigarette smoke, coal tar and coal tar pitch, soot and petroleum asphalt. This substance is used only for research purposes. Indene[1,2,3-cd]pyrene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0063458) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 53. Pharmacist
- [persons legally qualified by education and training to engage in the practice of pharmacy. ( CSP )] (UMLS (NCI) C0031323) =Professional or Occupational Group =health care personnel;
|
- 4. 1,4-Phenylenebis(methylene)selenocyanate
- (UMLS (NCI) C0167369) =Organic Chemical; Pharmacologic Substance ;
| - 54. Pharmacist license number
- (UMLS (HL7) C1549744) =Idea or Concept =Identifier type;
|
- 5. 1-(p-Hydroxyphenyl)-2-(1'-methyl-2'-phenoxy)ethylaminopropanol-1 Hydrochloride
- [The hydrochloride salt of isoxsuprine, a benzyl alcohol derivative with vasodilator activity. The mechanism of action of isoxsuprine hydrochloride is controversial because this drug has beta-adrenergic agonist activities that are not reversed by beta-adrenergic blockers. Although stimulation of the beta adrenergic receptor increases blood flow to produce vasodilatation, this drug may also have direct effects on the contractility of smooth muscle. Isoxsuprine hydrochloride also causes relaxation of uterine smooth muscle and may also produce positive inotropic and chronotropic effects on the myocardium. ( NCI )] (UMLS (NCI) C0282213) =Organic Chemical; Pharmacologic Substance =ISOXSUPRINE;
=ISOXSUPRINE HYDROCHLORIDE 10 MG;
ISOXSUPRINE HYDROCHLORIDE 20 MG | - 55. pharmacodynamics
- [The study of the biochemical and physiological effects of drugs and the mechanisms of their actions, including the correlation of actions and effects of drugs with their chemical structure, also, such effects on the actions of a particular drug or drugs. ( NCI )] (UMLS (CSP) C0851347) =Biologic Function
|
- 6. 1-phenyl-2-diethyl-amino-1-propanone Hydrochloride
- [A sympathomimetic amine structurally similar to amphetamine with anorexiant activity. Diethylpropion hydrochloride stimulates the central nervous system and increases the release of norepinephrine and dopamine from nerve terminals and inhibits their uptake. This suppresses appetite, increases motor activity, causes euphoria, mental alertness and excitement. This drug may also cause an increase in heart rate and blood pressure. Diethylpropion hydrochloride is used in the treatment of obesity. ( NCI )] (UMLS (NCI) C0282133) =Organic Chemical; Pharmacologic Substance ;
=DIETHYLPROPION;
=DIETHYLPROPION HYDROCHLORIDE 75 MG;
DIETHYLPROPION HYDROCHLORIDE 25 MG | - 56. pharmacogenetics
- [branch of genetics (the branch of science concerned with the means and consequences of transmission and generation of the components of biological inheritance) which deals with the genetic variability in individual responses to drugs and drug metabolism. ( CSP )] (UMLS (CSP) C0031325) =Biomedical Occupation or Discipline =Genetics;
Pharmacologic |
- 7. 1-Phenyl-Methyl-2-Piperazinyl-1H-Benzimidazole Hydrochloride
- [A drug that prevents or reduces nausea and vomiting. ( NCI )] (UMLS (NCI) C0758799) Lerisetron =Organic Chemical; Pharmacologic Substance ;
| - 57. Pharmacogenomics
- [While pharmacogenetics largely focuses on candidate genes, such as drug-metabolizing enzymes, pharmacogenomics broadens the scope of study to include all genes (ie, the genome). The latter approach takes into account that a patient's response to any given drug depends on numerous proteins in the body, such as metabolizing enzymes, transporters, receptors, and entire signaling networks mediating the response. Furthermore, genetic defects that underlie the disease process could determine the drug's effects even if they have no direct bearing on its mechanism of action. (from Medscape Pharmacotherapy) ( NCI )] (UMLS (NCI) C1138555) =Biomedical Occupation or Discipline ;
|
- 8. 1-Phosphatidylinositol 3-Kinase
- [An enzyme that catalyzes the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, V(D)J recombination and cell cycle checkpoints. (from LocusLink) ( NCI )] (UMLS (NCI) C0044602) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
| - 58. pharmacognosy
- [The science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic usage of plants is PHYTOTHERAPY. ( MSH )] (UMLS (CSP) C0031326) =Biomedical Occupation or Discipline
|
- 9. 1-Phosphatidylinositol 3-Kinase
- [Phosphoinositide-3-Kinase, Catalytic, Gamma Polypeptide, encoded by the PIK3CG gene, belongs to the PI3/PI4-kinase family of proteins. This protein is an enzyme that phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring. It is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In addition to its role in promoting assembly of adherens junctions, the protein is thought to play a pivotal role in the regulation of cytotoxicity in NK cells. (from LocusLink) ( NCI )] (UMLS (NCI) C0285761) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 59. PHARMACOKINETIC
- [A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI) ( NCI )] (UMLS (NCI) C0201734) =Research Activity
|
- 10. 1-Phosphatidylinositol Phosphodiesterase
- [Encoded by human PLCG2 Gene, 1265-aa 148-kDa Phospholipase C Gamma 2 is a crucial enzyme that generates DAG and IP3 second messengers in the transmembrane signaling of ligand-activated growth factor receptors. Containing a PI-PLC X-box catalytic domain, a PI-PLC Y-box catalytic domain, a C2 domain, a PH domain, 2 SH2 domains, and an SH3 domain, PLCG2 phospholipase activity increases upon phosphorylation on tyrosine residues following activation of growth factor and immune system receptors. (NCI) ( NCI )] (UMLS (NCI) C1377870) 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Gamma 2;
EC 3.1.4.11;
Phosphatidylinositol-Specific Phospholipase C-Gamma;
Phosphoinositide Phospholipase C;
Phospholipase C Gamma 2;
Phospholipase C, Gamma 2 (Phosphatidylyinositol-specific);
Phospholipase C-Gamma-2;
PI-Specific PLC Gamma;
PLCG2;
PLC-Gamma-2;
PLC-IV =Amino Acid, Peptide, or Protein; Enzyme | - 60. Pharmacologic
- [biological effects of drugs in living organisms or tissues; use this term mainly for intended, desired effects; for harmful or undesired effects, see DRUG ADVERSE EFFECT or TOXICOLOGY. ( CSP )] (UMLS (NCI) C0031330) =Biomedical Occupation or Discipline =Medical Science;
=drug administration route;
drug resistance;
drug tolerance;
neuropharmacology;
pharmacogenetics;
mechanism of action;
Pharmacology-Psychopharmacology;
chemical stimulation;
drug adverse effect;
DRUG WITHDRAWAL;
;
biliary tract pharmacology;
blood/lymphatic pharmacology;
cardiovascular pharmacology;
connective tissue pharmacology;
dental pharmacology;
drug classification;
ear pharmacology;
embryo/fetus pharmacology;
endocrine pharmacology;
eye pharmacology;
gastrointestinal pharmacology;
liver pharmacology;
muscle pharmacology;
neoplasm/cancer pharmacology;
pediatric pharmacology;
physical chemical interaction;
radiopharmacology;
receptor sensitivity;
reproductive system pharmacology;
respiratory pharmacology;
skeletal pharmacology;
skin pharmacology;
urinary tract pharmacology;
immunopharmacology;
Chemical Dependence;
|
- 11. 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Beta 3
- [Expressed in many tissues by human PLCB3 Gene, 1234-aa 139-kDa membrane-bound Phospholipase C Beta 3 contains a catalytic PI-PLC X-box domain, a catalytic PI-PLC Y-box domain, and a C2 domain. Activated in response to stimulation by hormones, growth factors, neurotransmitters, and other ligands, PLCB3 is a key enzyme in initiating receptor-mediated signal transduction by mediating production of DAG and IP3 second messengers. (NCI) ( NCI )] (UMLS (NCI) C1377871) Phosphoinositide Phospholipase C;
Phospholipase C Beta 3;
Phospholipase C Beta 3, Phosphatidylinositol-Specific;
PLCB3;
PLC-Beta-3 =Amino Acid, Peptide, or Protein; Enzyme | - 61. Pharmacologist
- [A physician, scientist, or healthcare provider that investigates the mechanisms underlying the effects of drugs and chemicals on biological or living systems. This knowledge is employed to help design and evaluate drugs for the prevention and treatment of disease. ( NCI )] (UMLS (NCI) C0260120) =Professional or Occupational Group ;
|
- 12. 1-Phosphatidylinositol-4-Phosphate 5-Kinase
- [Expressed ubiquitously (high in brain) by human PIP5K2A Gene (PtdIns(4)P-5-Kinase Family), 406-aa 46-kDa Phosphatidylinositol-4-Phosphate 5-Kinase Type II Alpha is a likely homodimer that catalyzes the phosphorylation of phosphatidylinositol-4-phosphate on the fifth hydroxyl of the myo-inositol ring to form phosphatidylinositol-4,5-biphosphate, the precursor to second messengers of phosphoinositide signal transduction pathways involved in regulation of secretion, cell proliferation, differentiation, and motility. PIP5K2A does not show homology to other kinases, but the protein does exhibit kinase activity. (NCI) ( NCI )] (UMLS (NCI) C1368110) 1-Phosphatidylinositol-4-Phosphate Kinase;
Diphosphoinositide Kinase;
Phosphatidylinositol-4-Phosphate 5-Kinase Type II Alpha;
PIP5K2A;
PIP5KII-Alpha;
PIPK;
PtdIns(4)P-5-Kinase;
Type II Phosphatidylinositol-4-Phosphate 5-Kinase 53 K;
=Amino Acid, Peptide, or Protein; Enzyme | - 62. Pharmacology and Toxicology
- [The science concerned with drugs together with the science concerned with the detection, chemical composition, and pharmacologic action of toxic substances or poisons and the treatment and prevention of toxic manifestations. ( NCI )] (UMLS (NCI) C0678735) =Occupation or Discipline
|
- 13. 1-Phosphatidylinositol-4-Phosphate Kinase
- [Abundantly expressed (6.3-kb mRNA) in many tissues, human PIP5K2B Gene (PtdIns(4)P-5-Kinase Family) encodes 416-aa plasma membrane targeted Phosphatidylinositol-4-Phosphate 5-Kinase Type II Beta, a homodimer 78% identical in sequence to PIP5K2A that catalyzes phosphorylation of phosphatidylinositol-4-phosphate on the fifth hydroxyl of the myo-inositol ring to form phosphatidylinositol-4,5-bisphosphate, precursor to second messengers of phosphoinositide signal transduction pathways involved in regulation of secretion, cell proliferation, differentiation, and motility. PIP5K isoforms possess almost no homology to kinase motifs in other phosphatidylinositol, protein, and lipid kinases. Conserved basic residues may form a dual specificity site for phosphatidylinositol 3- and 5-phosphates. PIP5K2B specifically interacts with the juxtamembrane region of TNFR1; PIP5K2B activity is increased by TNF-alpha. (NCI) ( NCI )] (UMLS (NCI) C1368108) Diphosphoinositide Kinase;
Phosphatidylinositol-4-Phosphate 5-Kinase Type II Beta;
PIP5KIIB;
PIPKII-Beta;
PTDINS(4)P-5-Kinase;
=Amino Acid, Peptide, or Protein; Enzyme | - 63. Pharmacology-Psychopharmacology
- [study of the effects of drugs on mental and behavioral activity. ( CSP )] (UMLS (NCI) C0033929) =Biomedical Occupation or Discipline ;
=Pharmacologic;
biological basis of behavior |
- 14. 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-
- [A phenazine dye with anti-mycobacterial and anti-inflammatory activity. The exact mechanism through which clofazime exerts its effect is unknown. However, it binds preferentially to mycobacterial DNA, thereby inhibiting DNA replication and cell growth. Clofazimine has a slow bactericidal effect on Mycobacterium leprae and is active against various other Mycobacteria. ( NCI )] (UMLS (NCI) C0008996) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =phenazine;
[AM900] ANTI-INFECTIVES, OTHER =CLOFAZIMINE 50 MG;
| - 64. pharmacophore
- [ ] (UMLS (CSP) C0599740) =Receptor ;
|
- 15. 2-Phenyl-1,3-propanediol Dicarbamate
- [A propanediol compound with anticonvulsant and antiepileptic properties. Although the exact mechanism of action is unknown, Felbamate may be an antagonist at the strychnine-insensitive glycine-recognition site of the N-methyl-D-aspartate (NMDA) receptor-ionophore complex, thereby blocking the effects of the excitatory amino acids, suppressing neuronal firing, and preventing seizure activity. Felbamate also has weak inhibitory effects on gamma-aminobutyric acid (GABA) receptor binding sites which may contribute to its inhibitory effect on neuronal excitatory. ( NCI )] (UMLS (NCI) C0060135) =Organic Chemical; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
propanediol =felbamate 120 MG/ML;
FELBAMATE 600 MG;
FELBAMATE 400 MG;
| - 65. Pharmacotherapy
- (UMLS (HL7) C1552222) =Intellectual Product =Pharmacist;
|
- 16. 2-Phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate
- (UMLS (NCI) C0054434) =Organic Chemical; Pharmacologic Substance ;
| - 66. Pharmacy
- (UMLS (HL7) C1547997) =Intellectual Product =Diagnostic Service Section ID;
|
- 17. 2-Phenylethylhydrazine Hydrogen Sulphate
- [A hydrazine derivative and a potent non-selective monoamine oxidase (MAO) inhibitor with anxiolytic and antidepressant properties. Phenelzine sulfate irreversibly binds to MAO, thereby blocking the oxidative deamination of monoamines resulting in an increased concentration of biogenic amines and a concurrent decrease in catabolism of monoamine neurotransmitters, norepinephrine and serotonin, in the brain. In addition, through its primary metabolite phenylethylidenehyrazine (PEH), phenelzine causes elevated GABA levels in the caudate-putamen and nucleus accumbens thereby exerting its anxiolytic effects. ( NCI )] (UMLS (NCI) C0031393) =Organic Chemical; Pharmacologic Substance ;
=PHENELZINE;
=PHENELZINE SULFATE 15 MG | - 67. Pharmacy
- [Location where healthcare service was delivered, identified as a pharmacy. ( HL7V3.0 )] (UMLS (HL7) C1555595) =Intellectual Product =DedicatedNonClinicalLocationRoleType;
◊ [A facility used by pharmacists for the compounding and dispensing of medicinal preparations (drug store). A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs through a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located. ( HL7V3.0 )] (UMLS (HL7) C1609627) Intellectual Product Supplier; |
- 18. 3-Phenyl-1H-naphtho[2,1-b]pyran-1-one
- [A polycyclic aromatic hydrocarbon that consists of a flavone group attached to a benzene ring. Beta-naphthoflavone is an inducer of the hepatic cytochrome p450 CYP1A1 and CYP1A2. ( NCI )] (UMLS (NCI) C0053490) =Organic Chemical; Pharmacologic Substance ;
| - 68. pharmacy administration
- [business, administration, and management of pharmacy services. ( CSP )] (UMLS (CSP) C0031337) =Occupational Activity =health administration;
|
- 19. 3-Phenylacetylamino-2, 6-piperidinedione
- [A piperidinedione antineoplaston with potential antineoplastic activity. Antineoplaston A10 was originally isolated from human urine but is now synthetically derived. This agent intercalates into DNA, resulting in cell cycle arrest in G1 phase, reduction of mitosis, and decreased protein synthesis. Antineoplaston A10 may also inhibit ras-oncogene expression and activate tumor suppressor gene p53, leading to cell differentiation and apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C0052080) =Organic Chemical; Pharmacologic Substance ;
| - 69. Pharmacy administration information
- (UMLS (HL7) C1546468) =Idea or Concept =What subject filter;
|
- 20. 3-Phosphoinositide Dependent Protein Kinase-1
- [3-Phosphoinositide Dependent Protein Kinase-1, encoded by the PDPK1 gene, belongs to the Ser/Thr family of protein kinases. This protein phosphorylates and activates not only PKB/AKT, but also PKA, PKC-zeta, p70S6K and p90S6K/RSK. It may play a general role in signaling processes and in development (by similarity). It becomes cytoplasmic and membrane-associated after cell stimulation leading to its translocation. Tyrosine phosphorylation seems to occur only at the plasma membrane. Three isoforms exist from alternative splicing and Isoform 3 is catalytically inactive. (from LocusLink) ( NCI )] (UMLS (NCI) C0541150) =Amino Acid, Peptide, or Protein; Enzyme
| - 70. Pharmacy dispense information
- (UMLS (HL7) C1546469) =Idea or Concept =What subject filter;
|
- 21. 3-Phosphoinositide Dependent Protein Kinase-1 Gene
- [This gene plays a role in cellular signaling and development. ( NCI )] (UMLS (NCI) C1335204) PDPK1;
PDPK1 Gene =Gene or Genome | - 71. Pharmacy encoded order information
- (UMLS (HL7) C1546470) =Idea or Concept =What subject filter;
|
- 22. 4-Phenylbutyric Acid
- (UMLS (NCI) C0170531) =Organic Chemical
| - 72. Pharmacy give information
- (UMLS (HL7) C1546472) =Idea or Concept =What subject filter;
|
- 23. 6 phosphofructokinase
- [An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. D-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. UTP, CTP, and ITP also are donors. In human phosphofructokinase-1, three types of subunits have been identified. They are PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; and PHOSPHOFRUCTOKINASE-1, C TYPE; found in platelets, brain, and other tissues. ( MSH )] (UMLS (CSP) C0031651) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
| - 73. Pharmacy Order Types
- (UMLS (HL7) C1547858) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Drug;
Other solution as medication orders;
IV Large Volume Solutions;
|
- 24. 9-(2-phophonylmethoxyethyl)adenine
- [an adenine analog, antiviral agent; used for treating hepatitis, HIV and African swine fever virus infections. ( CSP )] (UMLS (CSP) C0050175) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =[AM800] ANTIVIRALS;
Reverse Transcriptase Inhibitor;
adenine analog;
Unclassified Ingredients =Adefovir Dipivoxil;
| - 74. Pharmacy prescription information
- (UMLS (HL7) C1546473) =Idea or Concept =What subject filter;
|
- 25. PH
- [A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam. (NCI) ( NCI )] (UMLS (NCI) C0031529) =Geographic Area ;
=Asia;
Pacific Islands | - 75. Pharmacy Service Providers
- [A broad category grouping providers who render services relating to the preparation and dispensing of drugs. ( HL7V3.0 )] (UMLS (HL7) C1556039) =Intellectual Product =NUCC Health Care Provider Taxonomy;
=Pharmacist;
Pharmacy Technician;
|
- 26. Ph' Chromosome Negative Chronic Granulocytic Leukemia
- [A chronic myelogenous leukemia which does not express the Philadelphia chromosome abnormality. —2003 ( NCI )] (UMLS (NCI) C0279549) =Neoplastic Process
| - 76. Pharmacy Service Providers; Pharmacist
- [An individual who is licensed to prepare and sell or dispense drugs and compounds and to make up prescriptions. ( HL7V3.0 )] (UMLS (HL7) C1554664) =Professional or Occupational Group =HealthcareProviderTaxonomyHIPAA;
=Pharmacy Service Providers; Pharmacist; General Practice;
"Pharmacy Service Providers; Pharmacist; Nuclear Pharmacy"
;"Pharmacy Service Providers; Pharmacist; Nutrition Support"
;"Pharmacy Service Providers; Pharmacist; Pharmacotherapy"
;"Pharmacy Service Providers; Pharmacist; Psychopharmacy"
; |
- 27. Ph.D. Medical Genetics
- (UMLS (HL7) C1555779) =Intellectual Product =Medical Genetics;
◊ [A medical geneticist works in association with a medical specialist, is affiliated with a clinical genetics program, and serves as a consultant to medical and dental specialists.A general certificate was first issued by ABMS in 1982.ACGME Accredited Residency Program Requirements: None. ( HL7V3.0 )] (UMLS (HL7) C1556033) Intellectual Product Other Service Providers; | - 77. Pharmacy Service Providers; Pharmacist; General Practice
- (UMLS (HL7) C1554665) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 28. PHA
- [mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes; used mainly in the study of immune mechanisms and in cell culture. ( CSP )] (UMLS (CSP) C0031858) =Amino Acid, Peptide, or Protein; Immunologic Factor; Indicator, Reagent, or Diagnostic Aid =lectin;
| - 78. Pharmacy Service Providers; Pharmacist; Nuclear Pharmacy
- (UMLS (HL7) C1554666) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 29. PHACOLYTIC GLAUCOMA
- (UMLS (ICD9CM) C0152137) =Disease or Syndrome
| - 79. Pharmacy Service Providers; Pharmacist; Nutrition Support
- (UMLS (HL7) C1554667) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 30. phage display
- [Molecular biology technique that facilitates cloning or identification of specific proteins or peptides with a specific antigenic, ligand or protein-binding, enzymatic, or other biological property. It is based on the cloning of DNA within a phage coat protein gene so that the resulting protein is expressed as a fusion expressed on the surface of the phage. ( NCI )] (UMLS (CSP) C1519025) =Molecular Biology Research Technique =genetic technique;
| - 80. Pharmacy Service Providers; Pharmacist; Pharmacotherapy
- (UMLS (HL7) C1554668) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 31. Phage susceptibility typing
- [Identification, Phage susceptibility typing ( HL7V3.0 )] (UMLS (HL7) C1553141) =Laboratory Procedure =ObservationMethod;
| - 81. Pharmacy Service Providers; Pharmacist; Psychopharmacy
- (UMLS (HL7) C1554669) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 32. phagocytosis
- [engulfing of microorganisms, other cells, and foreign particles by phagocytic cells (phagocytes). ( CSP )] (UMLS (CSP) C0031308) =Cell Function =endocytosis;
=autophagy | - 82. Pharmacy Service Providers; Technician; Pharmacy
- (UMLS (HL7) C1554670) =Professional or Occupational Group =HealthcareProviderTaxonomyHIPAA;
|
- 33. Phagolysosome
- [A membrane-bounded intracellular vesicle formed by maturation of an early phagosome following the ingestion of particulate material by phagocytosis; during maturation, phagosomes acquire markers of late endosomes and lysosomes. [GOC:mah, PMID:12388753] ( GO )] (UMLS (NCI) C0031309) =Cell Component
| - 83. Pharmacy Technician
- (UMLS (HL7) C1619825) =Intellectual Product =Pharmacy Service Providers;
|
- 34. phagosome
- [Membrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material. ( MSH )] (UMLS (CSP) C0031310) =Cell Component
| - 84. Pharmacy/treatment administration acknowledgment message
- (UMLS (HL7) C1548108) =Idea or Concept =Message type;
|
- 35. Phalanx
- (UMLS (NCI) C0222682) =Body Part, Organ, or Organ Component
| - 85. Pharmacy/treatment administration information
- (UMLS (HL7) C1548086) =Idea or Concept =Message type;
|
- 36. Phalanyx
- (UMLS (HL7) C1550292) =Body Part, Organ, or Organ Component =Body Part;
| - 86. Pharmacy/treatment administration message
- (UMLS (HL7) C1548087) =Idea or Concept =Message type;
|
- 37. Phanerochaete chryosporium
- [ ] (UMLS (CSP) C0597971) =Fungus ;
| - 87. Pharmacy/treatment dispense acknowledgment message
- (UMLS (HL7) C1548109) =Idea or Concept =Message type;
|
- 38. phantom limb pain
- [The sensation of pain or other unpleasant feelings in the place of a missing (phantom) limb. ( NCI )] (UMLS (NCI) C0423699) =Disease or Syndrome
| - 88. Pharmacy/treatment dispense information
- (UMLS (HL7) C1548091) =Idea or Concept =Message type;
|
- 39. phantom model
- [device or object, often with properties similar to tissue, used in various imaging techniques, such as radiology and ultrasonography, to visualize or enhance visualization by simulating conditions encountered in the procedure; includes computer originated models used for such purposes; phantom models may be used for image interpretation, malignancy diagnosis, dosimetry, and as teaching aids to simulate real conditions with x-ray or ultrasonic machines. ( CSP )] (UMLS (CSP) C0597204) =Intellectual Product ;
=model;
| - 89. Pharmacy/treatment dispense message
- (UMLS (HL7) C1548092) =Idea or Concept =Message type;
|
- 40. Pharaoh Hound
- [The Pharaoh Hound is an athletic sight hound. The head is wedge-shaped and chiseled with large, erect ears and a powerful jaw. The flat skull and muzzle are long and slim. The coat is short and glossy in red or tan, often with white markings. It may also have a white tip on the tail, a white star on the chest, white on toes and/or a thin white line down the center of the face. Height: 21-25 inches (59-63 cm.) Weight: 45-55 pounds (20-25 kg.) ( NCI )] (UMLS (NCI) C0324411) =Mammal
| - 90. Pharmacy/treatment dose information
- (UMLS (HL7) C1548096) =Idea or Concept =Message type;
|
- 41. Pharmaceutical
- [Pharmaceutical care performed by a pharmacist. ( HL7V3.0 )] (UMLS (HL7) C1553890) =Intellectual Product =ActMedicalServiceCode;
| - 91. Pharmacy/treatment encoded order acknowledgment message
- (UMLS (HL7) C1548110) =Idea or Concept =Message type;
|
- 42. Pharmaceutical
- [practice of compounding and dispensing medicinal preparations; includes places where pharmaceutical drugs are sold (drug store). ( CSP )] (UMLS (NCI) C0031336) =Biomedical Occupation or Discipline =health care service;
| - 92. Pharmacy/treatment encoded order information
- (UMLS (HL7) C1548095) =Idea or Concept =Message type;
|
- 43. Pharmaceutical error
- (UMLS (HL7) C1547269) =Intellectual Product =Risk Management Incident Code;
| - 93. Pharmacy/treatment encoded order message
- (UMLS (HL7) C1548090) =Idea or Concept =Message type;
|
- 44. pharmaceutical policy
- [ ] (UMLS (CSP) C0600206) =Governmental or Regulatory Activity
| - 94. Pharmacy/treatment give acknowledgment message
- (UMLS (HL7) C1548111) =Idea or Concept =Message type;
|
- 45. Pharmaceutical substance is in the formulary
- (UMLS (HL7) C1547555) =Idea or Concept =Formulary Status;
| - 95. Pharmacy/treatment give message
- (UMLS (HL7) C1548097) =Idea or Concept =Message type;
|
- 46. Pharmaceutical substance is in the formulary, but guidelines apply
- (UMLS (HL7) C1547552) =Idea or Concept =Formulary Status;
| - 96. Pharmacy/treatment order acknowledgment message
- (UMLS (HL7) C1548061) =Idea or Concept =Message type;
|
- 47. Pharmaceutical substance is in the formulary, but restrictions apply
- (UMLS (HL7) C1547554) =Idea or Concept =Formulary Status;
| - 97. Pharmacy/treatment order message
- (UMLS (HL7) C1548059) =Idea or Concept =Message type;
|
- 48. Pharmaceutical substance is NOT in the formulary
- (UMLS (HL7) C1547553) =Idea or Concept =Formulary Status;
| - 98. Pharmacy/treatment order response
- (UMLS (HL7) C1548098) =Idea or Concept =Message type;
|
- 49. Pharmaceutical Substances
- (UMLS (HL7) C1547857) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 99. Pharyngeal Arch
- (UMLS (NCI) C0080322) =Embryonic Structure ;
|
- 50. Pharmaceuticals
- [ ] (UMLS (ICD9CM) C1135440) =Therapeutic or Preventive Procedure
| - 100. PHARYNGEAL BIOPSY
- [ ] (UMLS (ICD9CM) C0192210) =Diagnostic Procedure
|
home
